FDA ANDA · ANDA087796

HYDROCORTISONE

Sponsor: ACTAVIS MID ATLANTIC

APPLICATION

ANDA087796

TYPE

ANDA

ORIGINAL APPROVAL

1982-10-13

LATEST ACTION

2001-04-26

ROUTE

TOPICAL

DOSAGE FORM

OINTMENT

MARKETING STATUS

Discontinued

Products

HYDROCORTISONEDiscontinued

HYDROCORTISONE 1% · OINTMENT · TOPICAL

2001-04-26Manufacturing (CMC) · Supplement 15AP

2000-12-29Manufacturing (CMC) · Supplement 14AP

1999-03-26Manufacturing (CMC) · Supplement 13AP

1996-06-28Manufacturing (CMC) · Supplement 12AP

1996-02-07Manufacturing (CMC) · Supplement 11AP

1995-02-24Manufacturing (CMC) · Supplement 10AP

1994-02-09Labeling · Supplement 9AP

1993-05-17Labeling · Supplement 6AP

1992-03-04Labeling · Supplement 8AP

1989-07-26Manufacturing (CMC) · Supplement 7AP

1986-06-12Manufacturing (CMC) · Supplement 5AP

1986-06-12Manufacturing (CMC) · Supplement 4AP

1983-08-11Manufacturing (CMC) · Supplement 1AP

1982-10-13OriginalAP

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.